1994
DOI: 10.2214/ajr.163.1.8010197
|View full text |Cite
|
Sign up to set email alerts
|

Partial splenic embolization for the treatment of chronic idiopathic thrombocytopenic purpura.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

1
31
2
1

Year Published

1997
1997
2019
2019

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 59 publications
(35 citation statements)
references
References 12 publications
1
31
2
1
Order By: Relevance
“…Mozes et al [7] described the benefit of partial splenic embolization (PSE) in reducing the prevalence of complications from splenic artery embolization. Miyazaki et al [8] reported the effectiveness of PSE in thrombocytopenia. Their reports suggested that PSE might be a safe and effective alternative to splenectomy in the treatment of thrombocytopenia.…”
Section: Introductionmentioning
confidence: 99%
“…Mozes et al [7] described the benefit of partial splenic embolization (PSE) in reducing the prevalence of complications from splenic artery embolization. Miyazaki et al [8] reported the effectiveness of PSE in thrombocytopenia. Their reports suggested that PSE might be a safe and effective alternative to splenectomy in the treatment of thrombocytopenia.…”
Section: Introductionmentioning
confidence: 99%
“…The effects of PSE in some cases are temporary, necessitating a repeat procedure. With careful attention to a few technical principles, the incidence of complications after PSE has declined [10,11,14,16,17,20,22]. These principles, referred to as the Spigos technique, include (1) aseptic technique, (2) antibiotic coverage, (3) avoidance of excessive infarction of splenic mass (<60-70%), and (4) effective postembolization analgesia [15].…”
mentioning
confidence: 99%
“…Splenic artery embolization was first described in the 1970s and has since been used in different clinical settings, including traumatic spleen rupture, portal hypertension-related ascites, immune thrombocytopenic purpura, hemoglobinopathies, and hereditary spherocytosis [1][2][3][4][5]. Use of splenic embolization in patients with autoimmune hemolytic anemia is rarely reported [6].…”
Section: Discussionmentioning
confidence: 99%